Quantitative phosphoproteomic analyses of the inferior parietal lobule from three different pathological stages of Alzheimer's disease.
about
Clinical proteomics of enervated neuronsCollapsin Response Mediator Protein-2 (CRMP2) is a Plausible Etiological Factor and Potential Therapeutic Target in Alzheimer's Disease: Comparison and Contrast with Microtubule-Associated Protein TauClassification of Alzheimer's Disease, Mild Cognitive Impairment, and Cognitively Unimpaired Individuals Using Multi-feature Kernel Discriminant Dictionary Learning.Polyubiquitinylation Profile in Down Syndrome Brain Before and After the Development of Alzheimer Neuropathology.Oxidative Stress, Amyloid-β Peptide, and Altered Key Molecular Pathways in the Pathogenesis and Progression of Alzheimer's Disease.
P2860
Quantitative phosphoproteomic analyses of the inferior parietal lobule from three different pathological stages of Alzheimer's disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Quantitative phosphoproteomic ...... stages of Alzheimer's disease.
@en
Quantitative phosphoproteomic ...... stages of Alzheimer's disease.
@nl
type
label
Quantitative phosphoproteomic ...... stages of Alzheimer's disease.
@en
Quantitative phosphoproteomic ...... stages of Alzheimer's disease.
@nl
prefLabel
Quantitative phosphoproteomic ...... stages of Alzheimer's disease.
@en
Quantitative phosphoproteomic ...... stages of Alzheimer's disease.
@nl
P2093
P2860
P356
P1476
Quantitative phosphoproteomic ...... stages of Alzheimer's disease.
@en
P2093
Aaron M Swomley
Jon B Klein
Judy C Triplett
P2860
P356
10.3233/JAD-150417
P577
2015-09-22T00:00:00Z